RSV Vaccine Market

RSV Vaccine Market Share & Analysis – Industry Overview

Base Year: 2024 Historical Data: 2021-23
  • Report ID: TBI-14762
  • Published Date: Jun, 2025
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Segment Analysis

Regional segmentation analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global RSV vaccine market, with a 37% market revenue share in 2024.

The increased prevalence of RSV amongst such groups of ages as infants, children and the old makes vaccines very desirable. In North America, seasonal respiratory illnesses in RSV are common thus there has been increased focus on preventive measures such as vaccination. North America has a sophisticated healthcare system enabling better access to medical services and vaccine programs. The high investment by the region in the healthcare sector also is part of the critical strategy in distributing and administering the RSV vaccines to the population. In addition, strong support from government agencies and private enterprises also augments the market’s growth. The U.S government through cooperation with major pharma firms extensively supports the works carried out on RSV vaccines development, trials and distribution.

North America Region RSV vaccine Market Share in 2024 - 37%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Pfizer Inc. reported that the Advisory Committee on Immunisation Practices (ACIP) of the U.S. Centres for Disease Control and Prevention (CDC) voted to broaden its recommendation for the use of respiratory syncytial virus (RSV) vaccines that have been approved for adults aged 50 to 59 who are at a higher risk of developing lower respiratory tract disease (LRTD) linked to RSV. This includes the Respiratory Syncytial Virus Vaccine (ABRYSVO), which was licensed by the U.S. Food and Drug Administration in October 2024 to prevent RSV-associated LRTD in people who are at a higher risk of developing serious illness and are between the ages of 18 and 59.

Target population Segment Analysis

The target population segment is divided into infants and young children, elderly adults and immunocompromised individuals. The infants and young children segment dominated the market, with a market share of around 45% in 2024. The infants and young children population accounts for the largest market share in global RSV vaccine sales because these groups face significant risk from severe RSV infections. RSV stands as a principal respiratory pathogen for little children wherein premature infants specifically develop serious hospitalization complications. The combination of weak immune function from infancy and small airway dimensions makes infants highly susceptible to serious bronchiolitis and pneumonia diseases that can lead to mortal outcomes. A massive market exists for vaccines that protect infants from RSV because of its high infection rates among infants. Maternal immunization stands as the main element describing this dominant position. Scientific research indicates that pregnant woman vaccination provides the best defence against serious RSV infections which newborns experience. Expectant mothers receive the vaccine which transmits protective antibodies to their foetus that offers protection during the vulnerable period early in life. The worldwide medical sector champions protective measures for newborns from RSV infection which has led to increased development of vaccines for this demographic. Greater investment in RSV vaccines designed for infants has emerged because the healthcare sector increasingly recognizes the weight that RSV hospitalization costs impose on their systems.

  • A team of external experts from the U.S. Centres for Disease Control and Prevention suggested that younger adults who are more susceptible to serious disease from the virus should get vaccinated against respiratory syncytial virus. The 15-member panel recommended that at-risk people between the ages of 50 and 59 receive a single dose of the RSV vaccination by a vote of 14 to 0. People 75 years of age and older, as well as at-risk people 60 to 74 years of age, are currently advised to get the immunisation by the CDC.

Technology type Segment Analysis

The technology type segment is divided into protein-based vaccines, live-attenuated vaccines and mRNA vaccines. The protein-based vaccines segment dominated the market, with a market share of around 46% in 2024. Protein-based vaccines lead the RSV vaccine market because they show excellent safety results alongside high efficacy levels so healthcare providers use them for managing RSV complexities. Protein-based RSV vaccines provoke immune system protection against the virus through proteins that originate from natural RSV viral components especially the RSV F protein. The immune system develops protective immunity through this proteomic target during RSV infection while circumventing the requirement for exposure to living viruses thus minimizing any harmful effects. Protein-based vaccines maintain their position of prominence in developmental vaccine programs because they sustain a long-standing record of safety and effectiveness in using proteins derived from flu and hepatitis vaccines. The production of RSV protein-based vaccines proves simpler than alternative technologies including mRNA and live-attenuated vaccines. RSV protein-based vaccines enable effective customization for important risk groups. Ongoing RSV vaccine development mainly relies on protein-based vaccines because numerous clinical trials work to perfect the utilization of F protein to create strong immune responses.

  • The first maternal respiratory syncytial virus (RSV) vaccination was prequalified by the World Health Organisation (WHO) to shield newborns from one of the leading causes of acute lower respiratory infections in children worldwide. Global recommendations to implement passive immunisation (maternal vaccination and baby monoclonal antibodies) for the prevention of severe RSV disease in young newborns were made in September 2024 by the Strategic Advisory Group of Experts on Immunisation (SAGE). In March 2025, the maternal RSV vaccination was prequalified, demonstrating the Organization's dedication to enhancing health equity by accelerating access to life-saving medical items while simultaneously formulating recommendations.

End-user Segment Analysis

The end-user segment is divided into hospitals and clinics. The hospitals segment dominated the market, with a market share of around 65% in 2024. Hospitals stand out in RSV vaccination due to its criticality for the management of severe RSV infections and specialized care for those under increased risk. For infants, elderly adults, and immunocompromised, hospital settings often are the providers of their care as their severe RSV infections are extremely common. With available facilities, expertise on medical care and other outstanding resources, hospitals are well-prepared to offer vaccine administration to high-risk groups especially those requiring close medical attention after the vaccines. Hospital facilities capable of handling extreme medical conditions, capable of reacting rapidly to all reported adverse occurrences, enhance their standing as the superior provider of RSV vaccinations. As well, the increase in RSV hospitalizations exerts major pressure on healthcare systems leading to increased efforts to prevent severe infections through vaccination. Since hospitals are front line health care providers, they are important sites for vaccinations in vulnerable patients (premature infants and old people with other underlying conditions). Apart from dispensing vaccines, hospitals research and carry out important clinical trials that inform the advancement of RSV vaccines.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2021 to 2034. The Brainy Insights has segmented the global RSV vaccine market based on below mentioned segments:

Global RSV Vaccine Market by Target Population:

  • Infants and Young Children
  • Elderly Adults
  • Immunocompromised Individuals

Global RSV Vaccine Market by Technology Type:

  • Protein-Based Vaccines
  • Live-Attenuated Vaccines
  • mRNA Vaccines

Global RSV Vaccine Market by End-User:

  • Hospitals
  • Clinics

Global RSV Vaccine Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date